Commentary|Videos|November 19, 2026

Spotting Perimenopausal Depression in Primary Care, With Marlee Madora, MD

Fact checked by: Sydney Jennings

A reproductive psychiatrist on how to recognize perimenopausal depression in primary care, when hormone therapy fits, and when to refer to psychiatry.

The menopause transition is "a time of extreme psychiatric vulnerability," and primary care physicians should screen for perimenopausal depression rather than assume mood symptoms are simply hormonal, according to Marlee Madora, MD, a women’s mental health psychiatrist and assistant professor of Obstetrics, Gynecology, Women’s Health and Psychiatry at Montefiore Medical Center with Albert Einstein College of Medicine.

"Just because someone is in perimenopause does not mean that they're not meeting criteria for a major depressive episode," Madora said.

The risk of perimenopausal depression is well documented. In the Harvard Study of Moods and Cycles, women with no history of depression who entered perimenopause were nearly twice as likely to develop major depression as those who remained premenopausal (16.6% vs 9.5%).¹ Madora notes that this vulnerability often coincides with caregiving for children and aging parents, demanding jobs and new medical diagnoses.

She describes perimenopause and depression as overlapping circles in a Venn diagram. Vasomotor and urogenital symptoms sit on one side, and hopelessness and worthlessness on the other. Fatigue, low energy and sleep problems fall in the middle.

For patients with low mood, irritability, anxiety and poor sleep who do not meet full criteria for depression, Madora considers hormone therapy a strong first option because it can ease vasomotor symptoms and improve sleep. Hopelessness, worthlessness or thoughts of death call instead for suicide screening, a safety assessment and evidence-based treatment for depression. Guidelines on perimenopausal depression likewise name antidepressants and psychotherapy as front-line treatments for a major depressive episode.²

Madora also outlines when to refer to a reproductive psychiatrist, such as when symptoms persist despite hormone therapy and cognitive behavioral therapy for insomnia, or when a patient has had poor experiences with SSRIs or SNRIs.

Watch the video to hear Madora explain how to sort out which symptoms came first, and why that matters for treatment.


The following transcript has been lightly edited for style and flow.

Patient Care Online: How does the menopause transition affect mental health?

Madora: The menopause transition is a time of extreme psychiatric vulnerability. This time holds a 2-fold increased risk of depression compared with other times in the female lifespan. It can bring on someone's first episode of depression or a recurrence of depression that has happened before.

Perimenopause can lead to vasomotor symptoms, like hot flashes and night sweats, and these can affect someone's sleep and emotional well-being. It is also happening when women are stretched really thin. They might be caring for children and aging parents at the same time, as part of the sandwich generation. They may be holding new roles at work, going through relationship changes, or getting diagnosed with new medical conditions. So it is a time of extreme biological change, and it is also vulnerable because of these other sociocultural stressors.

Menopause is specifically when the period ends. Perimenopause is when there is extreme hormonal fluctuation. Perimenopause lasts 4 years on average, but it can last as long as 10 years. That is when women experience the most vasomotor symptoms, sleep changes, and mood changes, so it is much longer than many patients expect.

It is important to understand what is going on with your patient biologically and medically. Ask about their menstrual cycles and the hormonal changes they are experiencing. It is also important to understand what else is going on in their life and what other triggers there might be. Is this someone's first episode of depression, or is this a recurrence? And what came first? Did vasomotor symptoms disrupt sleep and then affect mood, or did the depression start well before any perimenopausal symptoms? That can help guide treatment.

PCO: What psychiatric symptoms are most commonly associated with perimenopause and menopause?

Madora: Common symptoms are low mood, irritability, increased anxiety, and especially sleep problems, both trouble falling asleep and staying asleep. Women often say, "All of a sudden, I do not feel like myself. I am not enjoying anything. I am unmotivated." There are also a lot of cognitive symptoms: low energy, poor concentration, and often difficulty with executive functioning.

PCO: How can primary care clinicians distinguish menopause-related mood changes from primary psychiatric disorders?

Madora: I like to think about perimenopause and psychiatric disorders as a Venn diagram. On one side are the physical symptoms of perimenopause, like vasomotor changes (hot flashes, night sweats) and urogenital changes. On the other side are depressive symptoms, like low mood, hopelessness, and worthlessness. In the middle is a large area of overlap, which includes low energy, fatigue, and sleep problems.

All of these symptoms can fluctuate and overlap. Just because someone is in perimenopause does not mean they are not also meeting criteria for a major depressive episode.

PCO: When should PCPs consider hormone therapy vs psychiatric treatment approaches?

Madora: Hormone therapy is a wonderful first-line treatment if someone does not meet full criteria for a major depressive episode. Some patients describe low mood, irritability, anxiety, and sleep problems but not low self-esteem, hopelessness, or worthlessness. That may be more in line with an adjustment disorder to this difficult medical time, and that is when hormone replacement therapy can be really helpful. It can improve vasomotor symptoms and sleep, and that can eventually improve someone's emotional well-being.

If the symptoms are more severe, with low mood, hopelessness, worthlessness, or thoughts of death, you should do a full suicide screening and safety assessment. Make sure the depression is treated appropriately with evidence-based therapy, medication, or both if the patient is open to it.


References

  1. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63(4):385-390. doi:10.1001/archpsyc.63.4.385
  2. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. J Womens Health (Larchmt). 2019;28(2):117-134. doi:10.1089/jwh.2018.27099.mensocrec

Related to this article